Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Progensa PCA3 test performance in post-oxytocin urine specimens
NL-OMON36233Phase 4Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Jun 2011
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of oxytocin, sponsored by Radboud University Medical Center. Primary endpoint: Yield of prostate cells in urine after oxytocin administration. Started Jun 2011; status: active, not recruiting.
02
Drugs
oxytocin
Beyond the preview
Go deeper on NL-OMON36233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36233.